Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility

European Radiology

Volumn 21, Issue 8, 2011, Pages 1713-1718

  Messiou, C ^a,b   Collins, D J ^a   Morgan, V A ^a   Desouza, N M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bone; Diffusion magnetic resonance imaging; Metastasis; Myeloma; Neoplasm

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BONE DISEASE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GROUPS BY AGE; HUMAN; MALE; METASTASIS; MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BONE MARROW; BONE MARROW NEOPLASMS; BONE NEOPLASMS; CASE-CONTROL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 80052682190     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2116-4     Document Type: Article

References (23)

1. Gauvain KM, McKinstry RC, Mukherjee P et al (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR 177:449-454. (Pubitemid 32660511)
2. Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53-60. (Pubitemid 29068231)
3. Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 188:1622-1635. (Pubitemid 46866868)
4. Charles-Edwards EM, deSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135-143.
5. Messiou C, deSouza NM (2010) Diffusion weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring. Cancer Biomark 6:23-32.
6. Nonomumra Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757-760. (Pubitemid 32381854)
7. Gutzeit A, Doert A, Froehlich JM et al (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333-343.
8. Goudarzi B, Kishimoto R, Komatsu S et al (2010) Detection of bone metastases using diffusion weighted magnetic resonance imaging:comparison with 11C-methionine PET and bone scintigraphy. Magn Reson Imaging 28:372-379.
9. Luboldt W, Küfer R, Blumstein N et al (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249:1017-1025.
10. Lee KC, Bradley DA, Hussain M et al (2007) A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9:1003-1011. (Pubitemid 350255347)
11. Lee KC, Sud S, Meyer CR et al (2007) An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res 67:3524-3528. (Pubitemid 46762131)
12. Reischauer C, Froehlich JM, Koh DM et al (2010) Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps - initial observations. Radiology 257:523-531.
13. Reese TG, Heid O, Weisskoff RM, Wedeen VJ (2003) Reduction of eddy-current induced distortion in diffusion MRI using twice refocused spin echo. Magn Reson Med 49:177-182. (Pubitemid 36042349)
14. Kingsley P (2006) Introduction to diffusion tensor imaging mathematics: part III. Tensor calculation, noise, simulations and opimisation. Concepts Magn Reson 28A:155-179. (Pubitemid 43550443)
15. Koh DM, Blackledge M, Collins D et al (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19:2728-2738.
16. Hatipoglu GH, Slevi A, Ciliz D, Yuksel E (2007) Quantitative and diffusion MR imaging as a new method to assess osteoporosis. AJNR 28:1934-1937. (Pubitemid 350174738)
17. Yeung DK, Wong SY, Griffith JF, Lau EM (2004) Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 19:222.
18. Griffith JF, Yeung DKW, Antonio GE et al (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241:831- 838. (Pubitemid 46190550)
19. Tang GY, Lv ZW, Tang RB et al (2010) Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Rad 65:377-381.
20. Wilkins BS (1992) Histology of normal haemopoiesis: bone marrow histology. I. J Clin Pathol 45:645-649.
21. Griffith JF, Yeung DK, Antonio GE et al (2005) Vertebral bone mineral density, marrow perfusion and fat content in normal and osteoporotic males: analysis using dynamic contrast enhanced NR and MR spectroscopy. Radiology 236:945-951. (Pubitemid 41170858)
22. Baur A, Huber A, Ertl-Wagner B et al (2001) Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR 22:366- 372. (Pubitemid 32163471)
23. Herneth AM, Philipp MO, Naude J et al (2002) Vertebral metastases: assessment with apparent diffusion coefficient. Radiology 225:889-894. (Pubitemid 35390381)